Pharma Pulse 4/9/25: Maintaining R&D Investments in the IRA Era, Pharmacists' Critical Role in Gene Therapy & more

Maintaining R&D Investments in the IRA Era

How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including resource allocation, pricing, and market access.

Pharmacists' Critical Role in Gene Therapy: Education, Collaboration, and Patient Care

In an interview with Pharmacy Times, Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, clinical pharmacy manager in the Blood and Marrow Transplant Program in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Cancer Center in Kansas City, Kansas, discussed how gene therapy treatments represent a complex and evolving field. The discussion was based on the presentation “The Pharmacist’s Role in Gene Therapy Treatments,” highlighted at the American Pharmacists Association (APhA) Annual Meeting & Exposition.

European Pharma Companies Warn of Exodus to US as Tariffs Loom

Pharmaceutical companies warned European Commission President Ursula von der Leyen of a potential exodus to the US as tariffs loom, an industry group said following a meeting Tuesday.

Weight Loss Drugs Market Global Research 2025-2035

The "Weight Loss Drugs Market - A Global and Regional Analysis: Focus on Type, Mechanism of Action, Route of Administration, Distribution Channel, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

The weight loss drugs market has experienced significant growth in recent years, largely driven by the increasing global prevalence of obesity and related health conditions. As more individuals seek effective and convenient solutions for managing their weight, the pharmaceutical industry has responded by offering a variety of drug options designed to aid in weight loss or help maintain a healthy weight.

François Mandeville on LinkedIn

Great to see John W. Arena, President of Global Pharma Services, featured in Pharmaceutical Executive. He shares valuable insights on the global launch challenges faced by emerging biopharma companies, emphasizing the need for strategic planning and partnerships with organizations like Cencora. As John says, "Our goal is to simplify the process and provide our partners with the support they need to accelerate speed-to-market."

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs